Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 121-127

  Stefani, Alessandro ^a,b,c   Calabresi, Paolo ^a   Pisani, Antonio ^a   Mercuri, Nicola B ^a   Siniscalchi, Antonio ^a,b   Bernardi, Giorgio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Associazione Anni Verdi   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; DIHYDROPYRIDINE; FELBAMATE; NIFEDIPINE; OMEGA CONOTOXIN GVIA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT THERAPY; ARTICLE; BRAIN PROTECTION; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; EPILEPTIC FOCUS; HUMAN; MALE; PRIORITY JOURNAL; RAT; SPIKE; STRUCTURE ANALYSIS;

ANIMALS; ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; CORPUS STRIATUM; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OMEGA-CONOTOXIN GVIA; PEPTIDES; PROPYLENE GLYCOLS; RATS; RATS, WISTAR;

EID: 0030430507     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. 2+ currents in acutely-isolated, adult rat neostriatal neurons. J. Neurosci. 14: 6667-6686, 1994
2. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J. Neurosci. 14: 187-197, 1994.
3. BURDETTE, D. E. AND SACKELLARES, J. C.: Felbamate pharmacology and use in epilepsy. Clin. Neuropharmacol. 17: 389-402, 1994.
4. CALABRESI, P., DE MURTAS, M., STEFANI, A., PISANI, A., SANCESARIO, G., MERCURI, N. B. AND BERNARDI, G.: Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission. Epilepsia 336: 991-996, 1995.
5. CALABRESI, P., MISGELD, U. AND DODT, H. U.: Intrinsic membrane properties of neostriatal neurons can account for their low level of spontaneous activity. Neuroscience 20: 293-303, 1987.
6. CALABRESI, P., PISANI, A., MERCURI, N. B. AND BERNARDI, G.: Post-receptor mechanisms underlying striatal long-term depression. J. Neurosci. 14: 4871-4881, 1994.
7. CHOI, D. W., KOH, J. AND PETERS, S.: Glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J. Neurosci. 8: 185-196, 1988.
8. CHRONOPOULOS, A., STAFSTROM, C., THURBER, S., HYDE, P., MIKATI, M. AND HOLMES, G. L.: Neuroprotective effects of felbamate after kainic acid-induced status epilepticus. Epilepsia 34: 359-366, 1993.
9. DESARRO, G. B , DESARRO, A. AND FEDERICO, F.: Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically epilepsy prone rats. Gen. Pharmacol. 21: 769-778, 1994.
10. DESARRO, G., ONGINI, E., BERTORELLI, R., AGUGLIA, U. AND DESARRO, A.: Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. Eur J. Pharmacol. 262: 11-19, 1994.
11. DICHTER, M. A. AND AYALA, G. F.: Cellular mechanisms of epilepsy: A status report. Science (Wash. DC) 237: 157-164, 1987.
12. DOMENICI, M. R., SAGRATELLA, S., ONGINI, E., LONGO R. AND SCOTTI DE CAROLIS, A: Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid antagonist. Eur. J. Pharmacol. 271: 259-263, 1995.
13. THE FELBAMATE STUDY GROUP IN LENNOX-GASTAUT SYNDROME: Efficacy of felbamate in childhood epileptic encefalopathy (Lennox-Gastaut Syndrome). N. Engl. J. Med. 328: 29-33, 1993.
14. FERRANTE, R. J., KOWALL, N. W. AND BEAL, M. F.: Selective sparing of a class of striatal neurons in Huntington's disease. Science (Wash. DC) 230: 561-563, 1987.
15. HEINEMANN, U., LUX, H. D. AND GUTNICK, M. J.: Extracellular free calcium and potassium during paroxysmal activity in the cerebral cortex of the cat. Exp. Brain Res. 27: 237-243, 1977.
16. HILLE, B.: Ionic Channels of Excitable Membranes, 2nd ed., Sinauer Associates, Boston, 1992.
17. HOEHN, K., WATSON, T. W. J. AND MACVICAR, B. A.: Multiple types of calcium channels in acutely isolated rat neostriatal neurons. J. Neurosci. 13: 1244-1257, 1993.
18. LARKIN, J. G., BESAG, F. M. C., COX, A. AND BEODIE, M. J.: Nifedipine for epilepsy? A double-blind, placebo-controlled study. Epilepsia 33: 346-352, 1992.
19. LIBRI, V. AND CONSTANTI, A.: Antagonism by felbamate of muscarmic and metabotropic receptor-mediated responses in guinea-pig olfactory cortex neurones in vitro. Proc. Pharmacol. Soc. 1994.
20. LORENZON, N. M. AND FOEHRIHG, R. C.: Characterization of pharmacologically identified voltage-gated calcium channels in acutely isolated rat neocortical neurons. I. Adult neurons. J. Neurophysiol. 73: 1430-1442, 1995.
21. MACDONALD, R. L. AND KELLY, K. M.: Antiepileptic mechanisms of action. Epilepsia 34: S1-S8, 1993.
22. MCCABE, R. T., WASTERLAIN, C. G., KUCHARCZYK, R., SOFIA, R. D. AND VOGEL, J. R.: Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J. Pharmacol. Exp. Ther. 264: 1248-1252, 1993.
23. 2+ channels. Neuron 9: 1163-1173, 1992.
24. NIGHTINGALE, S. L.: Recommendation to immediately withdraw patients from treatment with felbamate. J. Am. Med. Assoc. 272: 995, 1994
25. PISANI, A., STEFANI, A., SINISCALSCHI, A., MERCURI, N. B., BERNARDI, G. AND CALABRESI, P.: Electrophysiological actions of felbamate on rat striatal neurons. Br. J. Pharmacol. 116: 2053-2061, 1995.
26. RHO, J. M., DONEVAN, S. D. AND ROGAWSKI, M. A.: Mechanism of action of the anticonvuisant felbamate: Opposing effects on N-methyl-D-aspartate and γ-aminobutyric aeid (A) receptors. Ann. Neurol. 35: 229-234, 1994.
27. ROBINSON, H. P. C., KAWAHARA, M., JIMBO, Y., TOHIMITSU, K., KURODA, J. AND KAWANA, K.: Periodic synchronized bursting and intracellular calcium transients elicited by low magnesium in cultured cortical neurons. J. Neurophysiol. 70: 1606-1616, 1993.
28. ROTHMAN, S. M.: Excitotoxic neuronal death: Mechanisms and clinical relevance. Semin. Neurosci. 6: 315-322, 1994.
29. SACHDEO, R. C., KRAMER, I. D., ROSENBERG A. AND SACHDEO S.: Felbamate moriotherapy: Controlled trials in patients with partial onset seizures. Ann. Neurol. 32: 386-392, 1992.
30. SAYER, R. J., SCHWINDT, P. C. AND CHILL, W. E.: High- and low-threshold calcium currents in neurons acutely isolated from rat sensorimotor cortex. Neurosci. Lett. 120: 175-178, 1990.
31. SAYER, R J., BROWN, A. M., SCHWINDT, P. C. AND CRILL, W. E.. Calcium currents in acutely isolated human neocortical neurons. J. Neurophysiol. 69: 1596-1606, 1991.
32. SIESJO, B. K. AND BENGTSSON, F.: Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: A unifying hypothesis. J. Cerebr. Blood Flow Metab. 9: 127-140, 1989.
33. SIMON, R. P., SWAN, J. H., GRIFFITHS, T. AND MELDRUM, B. S.: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science (Wash. DC) 226: 850-852, 1986.
34. SPECKMANN, E.-J. AND WALDEN J.: Antiepileptic effects of organic calcium channel blockers in animal experiments. In Epilepsy. Models, Mechanisms and Concepts, ed. by P. A. Schwartzkroin, pp. 462-486, Cambridge University Press, Cambridge, 1989.
35. STEFANI, A., PISANI, A., DE MURTAS, M., MERCURI, N. B., MARCIANI, M. G., BERNARDI, G. AND CALABRESI P.: action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of HVA calcium currents. Epilepsia 336: 997-1002, 1995.
36. STEFANI, A., PISANI, A., MERCURI, N. B., BERNARDI, G. AND CALABRESI, P.: Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons. J. Neurosci. 14: 6734-6743, 1994a.
37. STEFANI, A., SURMEIER, D. J. AND BERNARDI, G.: Opioids modulate calcium conductances in rat striatal neurons. Brain Res. 642: 339-343, 1994b.
38. SWINYARD, E. A., SOFIA, E. D. AND KUPFERBERG, H. J.: Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Epilepsia 27: 27-34, 1986.
39. TAKAHASHI T. AND MOMIYAMA, A.: Different types of calcium channels mediate central synaptic transmission. Nature (Lond.) 366: 156-158, 1993.
40. TAYLOR, L. A., MCQUADE, R. D. AND TICE, A. B. FELBAMATE, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular calcium concentration. Eur. J. Pharmacol. 289: 229-233, 1995.
41. VAN LUOTELAAR, E. L. J. M., ATES, N. AND COENEN, A. M. L.: Role of L-type calcium channel modulation in nonconvulsive epilepsy in rats. Epilepsia 36: 86-92, 1995.
42. WALLIS, R. A., PANIZZON, K L., FAIRCHILD, M. D. AND WASTERLAIN, C. G.: Protective effects of felbamate against hypoxia in the rat hippocampal slice. Stroke 23: 547-551, 1992.
43. 3H]DCKA-labeled strychnine-insensitive glycine receptors in human postmortem brain. Exp. Neurol. 129: 244-250, 1994.
44. WASTERLAIN, C. G., ADAMS, L. M., HATTORI, H. AND SCHWARTZ, P. H.: Felbamate reduces hypoxic-ischemic brain damage in vivo. Eur J. Pharmacol. 212: 275-278, 1992.
45. WASTERLAIN, C. G., ADAMS, L. M., SCHWARTZ, P. H., HATTORI, H., SOFIA, R. D. AND WICHMANN, J. K.: Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia. Neurology 43: 2303-2310, 1993.
46. WURPEL, J. N. D AND IYER, S. N.: Calcium channel blockers verapamil and nimodipine inhibit kindling in adult and immature rats. Epilepsia 35: 443-449, 1994.